US captain Stacy Lewis unveiled the complete American roster for next month's Solheim Cup on Monday by adding Angel Yin, Cheyenne Knight and Ally Ewing...

On Mother's Day, ESPN thought it was a good time to ask Red Sox first baseman Triston Casas about his own mom, who is deceased.ESPN celebrated Mother's Day in its usual fashion. On Sunday Night Baseball, the trio of Karl Ravech, David Cone and Eduardo Perez spoke with players on the fi...

The Green Bay Packers' depth will be tested against the Detroit Lions

Arsenal’s new striker Kai Havertz has been described as some pundits as one of the Premier League’s great untapped talents – but he didn’t show that side in a recent challenge captured on social media. The 24-year-old German came in for mockery at the hands of Chelsea fans, his former club, after he failed to score a single point in the volleying portion of the MLS All-Star Skills Challenge. Havertz became the first person in the short history of the event to never score a single point in the cross-then-volley challenge. Sign up to our free Indy100 weekly newsletter Chelsea fans were delighted to see their former star, who they sold to rivals Arsenal for £65m last month, struggling at the event. One wrote: “Honestly, we tried to warn them [Arsenal] bro. They were too worried about ‘getting our best player’. We are just laughing all the way to the bank, big money, and free from this fraud. Tell me I get to watch free-flowing football again.” Arsenal fans, meanwhile, were disappointed with the performance. “It's not looking good honestly,” wrote one Gunners supporter. “I'm already getting livid especially after buying him for that amount. Let's hope he comes good.” Another Arsenal fan said: “We ordered the wrong Kai Havertz online.” “Now I understand why Mikel Arteta said Havertz will be playing in the midfield this season,” another fan wrote. However, ESPN journalist Herculez Gomez said: “Champions League Final winning goal. World Cup goals. Eff the memes. Remember that.” Havertz will hope to get the opportunity to show a more all-round skill set on Wednesday night during the MLS All-Star Game. Then, Arsenal will play Manchester United at MetLife Stadium in New Jersey, before taking on Barcelona in Los Angeles to wrap up their pre-season tour. Have your say in our news democracy. Click the upvote icon at the top of the page to help raise this article through the indy100 rankings.

Our canine companions could soon be enjoying much longer lifespans, if a drug which claims it can extend dogs’ lives eventually gets approved. The drug, made by a tech firm in California, just cleared a vital hurdle to doing just that, after it got partial approval by regulators in the US. Loyal, a San Francisco-based company founded in 2020, has been researching how it can increase dogs’ lifespans – in particular larger breeds, which tend to die younger. Large and “giant” breeds tend to live to between eight and 12 years. Smaller dogs, such as Chihuahuas, can keep going to the ripe old age of 20. Loyal’s main product, the catchily-titled LOY-001, is designed not only to extend dogs’ lives but also maintain their quality of life. Now, it has passed the “reasonable expectation of effectiveness” test, set by regulators at the US’ Food and Drug Administration. Loyal’s chief executive, Celine Halioua, said: "Loyal was founded with the ambitious goal of developing the first drugs to extend healthy lifespan in dogs. "This milestone is the result of years of careful work by the team. We'll continue to work just as diligently to bring this and our other longevity programs through to FDA approval." Selective breeding of dogs has caused higher levels of hormones which help the animals grow faster. That is also believed to reduce their lifespan, the company said. Big dogs tend to have more of this hormone than their smaller counterparts. Animal rights activists are not yet convinced. Some experts fear it will only serve to extend animals’ suffering. Loyal, on the other hand, says the drug aims to treat doggy diseases which are associated with ageing through preventing them, rather than waiting for the animals to get sick before treating them. The company said that the drug could be available to US customers as early as 2026. So that’s plenty of time for walkies between now and then. How to join the indy100's free WhatsApp channel Sign up to our free indy100 weekly newsletter Have your say in our news democracy. Click the upvote icon at the top of the page to help raise this article through the indy100 rankings.

As 'The Bachelorette' viewers notice a mysterious man in recent holiday photos, Gabby Windey raises relationship rumors

Captiv8, the creative agency responsible for connecting Dylan Mulvaney to Anheuser-Busch, was immediately terminated after the Bud Light controversy

The Hives are back with their first new music in 11 years and they've insisted they wanted their new album 'The Death Of Randy Fitzsimmons' to be 'stupid and childish' so it didn't venture into the territory of 'adult rock'

Tottenham Hotspur midfielder James Maddison has ben named the Premier League Player of the Month for August, beating off competition from the likes of Rodri and Jarrod Bowen.

'Bayonetta 3' receives new trailer and release date.

Microsoft has been given approval to buy Call of Duty developer Activision, clearing the way for one of the biggest ever tech deals. The Competition and Markets Authority (CMA) said the Xbox owner could go ahead with the takeover after agreeing to buy Activision without cloud gaming rights. It puts an end to a half-year long battle between the watchdog and Microsoft, having moved to block the deal in April. But businesses and their advisors should be in no doubt that the tactics employed by Microsoft are no way to engage with the CMA Sarah Cardell, CMA's chief executive The new deal, which was initially worth 69 billion US dollars (£56.6 billion at the current exchange rate), will stop Microsoft from having a “stranglehold” over the UK cloud gaming market, the CMA said. The regulator said it would preserve competitive prices for gamers and make sure consumers get more choice. Assassin’s Creed video game maker Ubisoft is set to buy Activision’s cloud gaming rights instead. But the CMA criticised Microsoft for “dragging out” proceedings during its investigation into the merger. Sarah Cardell, the CMA’s chief executive, said: “With the sale of Activision’s cloud streaming rights to Ubisoft, we’ve made sure Microsoft can’t have a stranglehold over this important and rapidly developing market. “But businesses and their advisors should be in no doubt that the tactics employed by Microsoft are no way to engage with the CMA. “Microsoft had the chance to restructure during our initial investigation but instead continued to insist on a package of measures that we told them simply wouldn’t work. “Dragging out proceedings in this way only wastes time and money.” Brad Smith, the president of Microsoft, said the group is “grateful” for the decision to approve the acquisition which he believes will “benefit players and the gaming industry worldwide”. Additional reporting by agencies Read More Incels using TikTok to spread ‘hateful beliefs’, research suggests Duke and Duchess of Sussex call for overhaul of social media Google to trial AI in UK traffic light systems to reduce stop-and-go emissions Broadband customers face £150 hikes because of ‘outrageous’ rises – Which? Rise of AI chatbots ‘worrying’ after man urged to kill Queen, psychologist warns William hails ‘amazing’ eco-friendly start-up businesses

The Chiefs have certainly enjoyed the spoils of their latest Super Bowl triumph during a busy offseason